The Senate Finance Committee rejected a proposal to require pharmaceutical companies to give bigger discounts to Medicare on drugs dispensed to older Americans with low incomes. The proposal, an amendment by Senator Bill Nelson, Democrat of Florida, would have required drug makers to provide Medicare with discounts in the form of rebates totaling more than $100 billion over 10 years.